Letter by Schomburg and Melander Regarding Article, “Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target”
Authors:
- 29 January 2019
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 139 (5) , 722-723
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Selenoprotein P Promotes the Development of Pulmonary Arterial HypertensionCirculation, 2018
- Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein PRedox Biology, 2017
- Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR StudyNutrients, 2015
- Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjectsThe American Journal of Clinical Nutrition, 2010
- Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trialThe American Journal of Clinical Nutrition, 2010